Year founded
-
Country of origin
Germany
HQ country
Germany
Total deal value
Average deal value
Company industry
- Healthcare & Pharmaceuticals
M&A expertise
- -
Industry expertise
- Healthcare & Pharmaceuticals
Probiodrug AG founded in 1997, is a biopharmaceutical company, engages in the research and development of therapeutic products for the treatment of Alzheimer’s disease in Germany. It focuses on lowering modified and toxic pyroglutamated (pGlu) Abeta in the brains of Alzheimer patients through the inhibition of glutaminyl cyclase (QC), as well as by immunotherapy with a modification-specific monoclonal antibody.